Expand JSPR Menu
JSPR MENU

JSPR Stock Posts


Unusual Option Volume

JSPR Jasper Therapeutics - Class A1.72-0.03 (-1.7%)

Jasper Therapeutics - Class A trades 2,393 contracts. The company has the following event: 8th Annual Evercore Healthcare Conference on Dec 3, 2025.
View Details...
Unusual Option Volume

JSPR Jasper Therapeutics - Class A3.68+0.66 (+21.9%)

Jasper Therapeutics - Class A trades 2,242 contracts. News: Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway
View Details...
Unusual Option Volume

JSPR Jasper Therapeutics - Class A3.38-3.39 (-50.1%)

Jasper Therapeutics - Class A trades 2,737 contracts. The company has the following event: Jasper Therapeutics Conference Call and Webinar on Briquilimab Clinical Data Update on Jul 7, 2025. News: Jasper Therapeutics Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria
View Details...
JSPR stock declines -66.2% in premarket,

Premarket Decliner

JSPR Jasper Therapeutics - Class A6.77-0.05-0.7%

Premarket:2.29-4.48 (-66.2%)

Jasper Therapeutics Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria

Globe NewswireMon, 7-Jul 7:30 AM
Unusual Option Volume

JSPR Jasper Therapeutics - Class A7.14-10.57 (-59.7%)

Jasper Therapeutics - Class A trades 2,214 contracts. The company has the following event: Webinar to Present Preliminary Data from the BEACON Study of Briquilimab in Chronic Spontaneous Urticaria on Jan 8, 2025. News: Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
View Details...
Unusual Option Volume

JSPR Jasper Therapeutics - Class A18.50-2.37 (-11.4%)

Jasper Therapeutics - Class A trades 2,372 contracts. The company has the following event: Webinar to Present Preliminary Data from the BEACON Study of Briquilimab in Chronic Spontaneous Urticaria on Jan 8, 2025.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes